Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 38Gynecologic 22Gastrointestinal 19Genitourinary 14Other 12Thoracic 11Other solid neoplasm 8Other hematologic neoplasm 8Tumor-Agnostic 6Head & Neck 6Lymphoid 5Other neoplasm 3Sarcoma 2Plasma cell 2Myeloid 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Ovarian Neoplasms 1Fanconi Anemia, Complementation Group D1 1Breast Neoplasms 1

Interventions

Cyclophosphamide 93fludarabine phosphate 86Busulfan 63Cyclosporine 57Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53Epoetin Alfa 53Antilymphocyte Serum 43fludarabine 42Filgrastim 41Cytarabine 41Tacrolimus 39Melphalan 38Darbepoetin alfa 38Methotrexate 34Radiotherapy 32Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23Methylprednisolone 21Etoposide 21apixaban 18eltrombopag 16Thiotepa 16Dalteparin 16ferric carboxymaltose 14Daunorubicin 14Azacitidine 14Alemtuzumab 14thymoglobulin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Counseling × Classical hematology × Clear all
NCT00001806 2019-12-12

Methods in Education for Breast Cancer Genetics

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
170 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡